BCD-148
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BCD-148, covering 2020-05-15 to 2025-05-29. Get the full timeline:
Most recent: Clinical Trial Update: An Extension Clinical Study of BCD-148 for the Treatment of Patients With PNH Previously Treated in Clinical Study No. BCD-148-2/NOCTURN [Phase 3]